UA118576C2 - Фармацевтична композиція, яка містить бринзоламід - Google Patents

Фармацевтична композиція, яка містить бринзоламід

Info

Publication number
UA118576C2
UA118576C2 UAA201608992A UAA201608992A UA118576C2 UA 118576 C2 UA118576 C2 UA 118576C2 UA A201608992 A UAA201608992 A UA A201608992A UA A201608992 A UAA201608992 A UA A201608992A UA 118576 C2 UA118576 C2 UA 118576C2
Authority
UA
Ukraine
Prior art keywords
brinzolamide
pharmaceutical composition
formulation
soluplus
manufacturability
Prior art date
Application number
UAA201608992A
Other languages
English (en)
Inventor
Мандар В. ШАХ
Дипак Бахрі
Original Assignee
Сентис Фарма Прайвет Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сентис Фарма Прайвет Лімітед filed Critical Сентис Фарма Прайвет Лімітед
Publication of UA118576C2 publication Critical patent/UA118576C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Розкриті стерильний водний склад інгібітору карбоангідрази, такого як бринзоламід, у комбінації з полімерами, такими як Солюплюс®, і поверхнево-активною речовиною, такою як полісорбат 80, а також способи його одержання. Склад належить до високосолюбілізованої або аморфної форми поганорозчинних лікарських сполук/діючого інгредієнта (діючих інгредієнтів) для поліпшення їх біодоступності і технологічності.
UAA201608992A 2014-01-24 2015-01-23 Фармацевтична композиція, яка містить бринзоламід UA118576C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN223DE2014 2014-01-24
PCT/IB2015/050511 WO2015110993A1 (en) 2014-01-24 2015-01-23 Pharmaceutical composition comprising brinzolamide

Publications (1)

Publication Number Publication Date
UA118576C2 true UA118576C2 (uk) 2019-02-11

Family

ID=53680901

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201608992A UA118576C2 (uk) 2014-01-24 2015-01-23 Фармацевтична композиція, яка містить бринзоламід

Country Status (8)

Country Link
US (2) US10632198B2 (uk)
EP (1) EP3096740B1 (uk)
JP (1) JP6487452B2 (uk)
EA (1) EA036820B1 (uk)
ES (1) ES2838756T3 (uk)
PT (1) PT3096740T (uk)
UA (1) UA118576C2 (uk)
WO (1) WO2015110993A1 (uk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016063184A1 (en) * 2014-10-20 2016-04-28 Sentiss Pharma Private Limited Ophthalmic solution
CN105796482B (zh) * 2016-04-19 2019-09-03 浙江工业大学 紫杉醇缓释温敏凝胶及其制备方法
US20190209465A1 (en) * 2016-07-01 2019-07-11 Pharmathen S.A. Process for preparing pharmaceutical ophthalmic compositions of brinzolamide
BR112019008239A2 (pt) 2016-11-02 2019-07-16 Centrexion Therapeutics Corp formulações aquosas, estáveis, injetáveis de capsaicina e uso médicos dos mesmos
AU2018302342B2 (en) 2017-07-20 2024-08-08 Centrexion Therapeutics Corporation Methods and compositions for treatment of pain using capsaicin
AU2018318123B2 (en) * 2017-08-15 2024-07-25 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
EP3784286A4 (en) * 2018-04-25 2022-03-02 Shilpa Medicare Limited BRINZOLAMIDE OPHTHALMIC COMPOSITIONS
MX2021002230A (es) * 2018-08-28 2021-05-27 Cloudbreak Therapeutics Llc Formulaciones en emulsion de inhibidores de multicinasa.
CN114557955B (zh) * 2018-09-25 2024-06-18 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378703A (en) 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
US5153192A (en) 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
JPH08501303A (ja) * 1992-09-17 1996-02-13 アルコン ラボラトリーズ，インコーポレイテッド 局所用炭酸脱水酵素阻害剤組成物
US6071904A (en) 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
WO1999063968A1 (fr) * 1998-06-10 1999-12-16 Wakamoto Pharmaceutical Co., Ltd. Preparations aqueuses contenant des medicaments faiblement solubles
TWI544927B (zh) * 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
JP2010037327A (ja) * 2008-07-07 2010-02-18 Wakamoto Pharmaceut Co Ltd ブリンゾラミド水性組成物
EP2506878A2 (en) * 2009-12-03 2012-10-10 Lupin Limited Process for preparing pharmaceutical ophthalmic compositions
US8211450B2 (en) * 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
CA2841969A1 (en) * 2011-07-20 2013-01-24 Allergan, Inc. Fixed dose combination of bimatoprost and brimonidine
US20130065888A1 (en) * 2011-08-15 2013-03-14 Biserka Cetina-Cizmek Ophthalmic formulations and processes for their preparation
RU2014129268A (ru) * 2011-12-16 2016-02-10 Аллерган, Инк. Офтальмологические составы, которые содержат привитые сополимеры поливинилкапролактам-поливинилацетат-полиэтиленгликоля
WO2013175285A1 (en) * 2012-05-21 2013-11-28 Aurobindo Pharma Limited Process for preparing ophthalmic suspension of brinzolamde

Also Published As

Publication number Publication date
EA201691490A1 (ru) 2016-12-30
EP3096740B1 (en) 2020-09-30
ES2838756T3 (es) 2021-07-02
JP2017503805A (ja) 2017-02-02
WO2015110993A1 (en) 2015-07-30
US20160339105A1 (en) 2016-11-24
US10632198B2 (en) 2020-04-28
US11826429B2 (en) 2023-11-28
US20200197522A1 (en) 2020-06-25
PT3096740T (pt) 2020-12-24
EP3096740A1 (en) 2016-11-30
EA036820B1 (ru) 2020-12-23
WO2015110993A4 (en) 2015-10-15
JP6487452B2 (ja) 2019-03-20

Similar Documents

Publication Publication Date Title
UA118576C2 (uk) Фармацевтична композиція, яка містить бринзоламід
WO2016131067A3 (en) Pharmaceutical compositions comprising meloxicam
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
WO2015165413A8 (zh) 一种新型的稳定型抗体药物耦联物及其制备方法和用途
NZ631100A (en) Soft chewable pharmaceutical products
WO2017037594A3 (zh) 用于减少局部脂肪的医药组成物及其用途
MX2011007817A (es) Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion.
MX2016010179A (es) Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer.
EP3513789A3 (en) Prophylactic and therapeutic agents for fgfr3 diseases
EP4233902A3 (en) Treatment of a disease of the gastrointestinal tract with an integrin inhibitor
IN2014MN01470A (uk)
WO2016065096A8 (en) Platinum-catalyzed silicone drug delivery devices and methods of use thereof
PH12015502556A1 (en) Modified release formulation
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
WO2016040814A3 (en) Disulfide polymers and methods of use
WO2012085284A3 (en) High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
JO3587B1 (ar) أشكال جرعات بينداموستين عن طريق الفم
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
WO2012147101A3 (en) Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
BR112017019364A2 (pt) dispersões sólidas
EA201500128A1 (ru) Педиатрические жидкие композиции для перорального введения, содержащие непадутант
WO2013127539A3 (de) Pharmazeutische formulierung enthaltend flupirtin
MY194591A (en) Pharmaceutical combination formulation
TH167851A (th) (s)-เพอร์ลินโดล และเกลือที่ยอมรับได้ทางเภสัชกรรมของมันสำหรับ การใช้ในยารักษาโรค
UA114828C2 (uk) Застосування декаметоксину як фармацевтично активної речовини для лікування шлунково-кишкових та кишкових інфекцій перорально